发明名称 AMINOTHIAZOLES AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS
摘要 Compounds of formula (I) in free or salt form, where A is a C<SUB>6</SUB>-C<SUB>15 </SUB>monovalent aromatic group. R<SUP>1 </SUP>is hydrogen, phenyl optionally substituted by one or more substituents selected from halogen, cyano, hydroxy, C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl, C<SUB>1</SUB>-C<SUB>8</SUB>-haloalkyl, C<SUB>1</SUB>-C<SUB>8</SUB>-alkoxy, C<SUB>1</SUB>-C<SUB>8</SUB>-alkoxy-C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl or acyloxy, or a 5- or 6-membered monovalent heterocyclic group, R<SUP>2 </SUP>is hydrogen, C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl, acyl or CON(R<SUP>3</SUP>)R<SUP>4</SUP>, provided that R<SUP>2 </SUP>is C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl, acyl or CON(R<SUP>3</SUP>)R<SUP>4 </SUP>when R<SUP>1 </SUP>is hydrogen, R<SUP>3 </SUP>and R<SUP>4 </SUP>are each independently hydrogen, or C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl, together with the nitrogen atom to which they are attached denote a 5- or 6-membered heterocyclic group, and Z<SUP>l</SUP>, Z<SUP>2</SUP>, Z<SUP>3 </SUP>and Z<SUP>4 </SUP>are each independently N or CR<SUP>5</SUP>, at least one of them being CR<SUP>5</SUP>, and R<SUP>5 </SUP>is hydrogen, C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl or C<SUB>1</SUB>-C<SUB>8</SUB>-alkoxy. The compounds are useful as adenosine receptor antagonists, particularly in the treatment of inflammatory or obstrucive airways diseases
申请公布号 PL361842(A1) 申请公布日期 2004.10.04
申请号 PL20010361842 申请日期 2001.11.19
申请人 NOVARTIS AG 发明人 PRESS NEIL JOHN;TAYLOR ROGER JOHN
分类号 C07D417/04;A61K31/427;A61K31/4439;A61K31/497;A61K45/00;A61P1/04;A61P1/12;A61P1/16;A61P3/10;A61P7/00;A61P7/06;A61P9/10;A61P11/00;A61P11/02;A61P11/06;A61P11/08;A61P13/12;A61P17/00;A61P17/06;A61P17/14;A61P17/16;A61P19/00;A61P21/04;A61P25/28;A61P27/02;A61P27/06;A61P27/14;A61P29/00;A61P35/00;A61P37/02;A61P37/08;A61P43/00;C07D417/14;C07D521/00 主分类号 C07D417/04
代理机构 代理人
主权项
地址